Laboratorios Richmond SACIF

Laboratorios Richmond SACIF Intangible Assets

The Intangible Assets of Laboratorios Richmond SACIF (RICH.BA) as of Nov 22, 2026 is 26.08 B ARS. In the previous year, Intangible Assets was 12.75 B ARS — a change of 104.59% (higher).

Intangible Assets

26.08 BARS

YoY

104.59%

Last updated:

Intangible Assets of Laboratorios Richmond SACIF is 2024 26.08 B ARS. Intangible Assets of Laboratorios Richmond SACIF was 2023 12.75 B ARS. It decreases by 104.59% higher compared to the previous year.

The Laboratorios Richmond SACIF Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
60.67 M ARS
Jan 1, 2018
220.45 M ARS
Jan 1, 2019
457.08 M ARS
Jan 1, 2020
990.28 M ARS
Jan 1, 2021
2.85 B ARS
Jan 1, 2022
3.34 B ARS
Jan 1, 2023
12.75 B ARS
Jan 1, 2024
26.08 B ARS
The Laboratorios Richmond SACIF Intangible Assets history
YEARIntangible AssetsYoY
26.08 BARS+104.59%
12.75 BARS+282.14%
3.34 BARS+17.05%
2.85 BARS+187.77%
990.28 MARS+116.66%
457.08 MARS+107.34%
220.45 MARS+263.35%
60.67 MARS+240.69%
17.81 MARS+131.28%
7.70 MARS+1.32%
7.60 MARS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Laboratorios Richmond SACIF Stock analysis

What does Laboratorios Richmond SACIF do? Laboratorios Richmond SACIF is a specialized pharmaceutical company focused on the manufacturing and marketing of medications. It was founded in 1935 and is headquartered in Buenos Aires, Argentina. The company has extensive experience in the development of medications and biological products, with expertise in pharmaceutical research and development. It has various business divisions including generics, biological medications, vaccines, oncology medications, and medical devices. The company's products range from simple painkillers and antihistamines to important medications for treating cancer and HIV. Richmond SACIF also manufactures vaccines against diseases such as Hepatitis A and B, polio, influenza, tetanus, and other infectious diseases. Additionally, the company produces a wide range of medications for treating different types of cancer and offers medical instruments and surgical devices. Its business model focuses on innovation and meeting the needs of patients, investing in research and development to develop new and innovative products. The company also has strict quality control measures to ensure the highest pharmaceutical standards. With its rich history and broad range of products, Laboratorios Richmond SACIF is a key player in the global pharmaceutical market and will continue to play an important role in improving the health of people worldwide. Laboratorios Richmond SACIF is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laboratorios Richmond SACIF stock

Intangible Assets of Laboratorios Richmond SACIF is 26.08 B ARS in 2024.

Intangible Assets of Laboratorios Richmond SACIF changed from 12.75 B ARS to 26.08 B ARS, representing a 104.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Laboratorios Richmond SACIF since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's ARS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Laboratorios Richmond SACIF historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Laboratorios Richmond SACIF

All Key Metrics — Laboratorios Richmond SACIF